newsfilter
← Latest News
GlobeNewswire·

Observed Safety Profile Supports Bilateral Dosing of ProKidney's REACT™ – 007 Update

Potential for Amplified Therapeutic Effect of REACT™ with Bilateral Kidney Injections Potential to report data from enhanced delivery approach 1Q 2023 WINSTON-SALEM, N.C., June 07, 2022 (GLOBE NEWSWIRE) -- ProKidney LP ("ProKidney"), a leading